White Oak Capital Dumps 2% Stake in Viyash Scientific

White Oak Capital Management Consultants LLP sold 8,747,392 shares of Viyash Scientific.
This represents a 2.00% reduction in equity share capital.

Reader Takeaway: Institutional selling reduces supply overhang but signals profit-taking or portfolio rebalancing from major investors.

What just happened

White Oak Capital Management Consultants LLP executed a significant divestment in Viyash Scientific Ltd. On October 15, 2026, the firm sold 8,747,392 shares through an open market transaction. This sale brings the firm's total shareholding in the company down to 0.14%, from a previous position of 2.14%.

Why this matters

Large institutional stake sales often influence short-term price action and liquidity. As White Oak held these shares across multiple funds—including Dendana Investments (Mauritius) Limited, Ashoka India Equity Investment Trust Plc, and India Acorn Fund—the coordinated exit of 2% of the company's equity suggests a strategic shift by the fund managers involved. Shareholders should note that the entity's remaining exposure of 0.14% is now nominal.

The backstory

The disclosure follows standard regulatory compliance under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The firm previously held 9,353,641 shares before the sale and now holds 606,249 shares.

What to track next

Investors should monitor the upcoming bulk or block deal reports to identify who absorbed the 2% equity stake. Additionally, watch for Viyash Scientific’s next shareholding pattern filing to determine if other institutional investors are adjusting their positions in light of this divestment.